rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Lucy To

Officer

Company insider

Files Form 4 as: Officer, SAB Biotherapeutics.

In numbers

Trades disclosed
4
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
1
Companies where not an officer
0
First trade
12 Aug 2024
Last trade
3 Feb 2026
Last filed
5 Feb 2026

Companies traded

Where they are an officer
SABS SAB BiotherapeuticsOfficer · Biotechnology · last 3 Feb 20260 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
3 Feb 2026filed 5 Feb 2026SABS SAB Biotherapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—2,400,000 at $0.00filing
3 Feb 2026filed 5 Feb 2026SABS SAB Biotherapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—2,400,000 at $0.00filing
26 Aug 2025filed 28 Aug 2025SABS SAB Biotherapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—1,200,000 at $0.00filing
12 Aug 2024filed 13 Aug 2024SABS SAB Biotherapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—125,000 at $0.00filing

Sectors

No trade we could place in a sector.

Related people

Alexandra KropotovaDirector · Chief Medical Officer at SAB Biotherapeutics, filing Form 4 there in the last year
Eddie Joe SullivanPresident · President at SAB Biotherapeutics, filing Form 4 there in the last year
Christoph Lawrence BauschChief Operating Officer · Chief Operating Officer at SAB Biotherapeutics, filing Form 4 there in the last year
Samuel J. ReichCEO · CEO at SAB Biotherapeutics, filing Form 4 there in the last year
David ZaccardelliDirector · Director at SAB Biotherapeutics, filing Form 4 there in the last year